Literature DB >> 3498941

Growth of human hemopoietic colonies in response to recombinant gibbon interleukin 3: comparison with human recombinant granulocyte and granulocyte-macrophage colony-stimulating factor.

H A Messner1, K Yamasaki, N Jamal, M M Minden, Y C Yang, G G Wong, S C Clark.   

Abstract

Supernatants of COS-1 cells transfected with gibbon cDNA encoding interleukin 3 (IL-3) with homology to sequences for human IL-3 were tested for ability to promote growth of various human hemopoietic progenitors. The effect of these supernatants as a source of recombinant IL-3 was compared to that of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) as well as to that of medium conditioned by phytohemagglutinin-stimulated leukocytes. The frequency of multilineage colonies, erythroid bursts, and megakaryocyte colonies in cultures containing the COS-1 cell supernatant was equivalent to the frequency observed in the controls and significantly higher than found in cultures plated with recombinant GM-CSF. G-CSF did not support the formation of multilineage colonies, erythroid bursts, and megakaryocyte colonies. In contrast, growth of granulocyte-macrophage colonies was best supported with GM-CSF, while recombinant IL-3 yielded colonies at lower or at best equivalent frequency. The simultaneous addition of higher concentrations of GM-CSF to cultures containing IL-3 in optimal amounts did not enhance the formation of multilineage colonies, erythroid bursts, and megakaryocyte colonies. However, the frequency of such colonies and bursts increased with GM-CSF when cultures were plated with suboptimal concentrations of IL-3. Growth of colonies within the granulocyte-macrophage lineage is optimally supported by GM-CSF and does not increase with further addition of IL-3.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498941      PMCID: PMC299165          DOI: 10.1073/pnas.84.19.6765

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor (CSF-1).

Authors:  E S Kawasaki; M B Ladner; A M Wang; J Van Arsdell; M K Warren; M Y Coyne; V L Schweickart; M T Lee; K J Wilson; A Boosman
Journal:  Science       Date:  1985-10-18       Impact factor: 47.728

2.  Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells.

Authors:  L M Souza; T C Boone; J Gabrilove; P H Lai; K M Zsebo; D C Murdock; V R Chazin; J Bruszewski; H Lu; K K Chen; J Barendt; E Platzer; M A S Moore; R Mertelsmann; K Welte
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

3.  Cloning and expression of the human erythropoietin gene.

Authors:  F K Lin; S Suggs; C H Lin; J K Browne; R Smalling; J C Egrie; K K Chen; G M Fox; F Martin; Z Stabinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

4.  Purification of fetal hematopoietic progenitors and demonstration of recombinant multipotential colony-stimulating activity.

Authors:  S G Emerson; C A Sieff; E A Wang; G G Wong; S C Clark; D G Nathan
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

5.  Identification of pure and mixed basophil colonies in culture of human peripheral blood and marrow cells.

Authors:  A G Leary; M Ogawa
Journal:  Blood       Date:  1984-07       Impact factor: 22.113

6.  Human recombinant granulocyte-macrophage colony-stimulating factor: a multilineage hematopoietin.

Authors:  C A Sieff; S G Emerson; R E Donahue; D G Nathan; E A Wang; G G Wong; S C Clark
Journal:  Science       Date:  1985-12-06       Impact factor: 47.728

7.  Genomic cloning, characterization, and multilineage growth-promoting activity of human granulocyte-macrophage colony-stimulating factor.

Authors:  K Kaushansky; P J O'Hara; K Berkner; G M Segal; F S Hagen; J W Adamson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

8.  Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor.

Authors:  S Nagata; M Tsuchiya; S Asano; Y Kaziro; T Yamazaki; O Yamamoto; Y Hirata; N Kubota; M Oheda; H Nomura
Journal:  Nature       Date:  1986 Jan 30-Feb 5       Impact factor: 49.962

9.  Biologic properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor.

Authors:  D Metcalf; C G Begley; G R Johnson; N A Nicola; M A Vadas; A F Lopez; D J Williamson; G G Wong; S C Clark; E A Wang
Journal:  Blood       Date:  1986-01       Impact factor: 22.113

10.  Permissive role of interleukin 3 (IL-3) in proliferation and differentiation of multipotential hemopoietic progenitors in culture.

Authors:  T Suda; J Suda; M Ogawa; J N Ihle
Journal:  J Cell Physiol       Date:  1985-08       Impact factor: 6.384

View more
  11 in total

1.  Transcriptional regulation of interleukin 3 gene expression in T lymphocytes.

Authors:  S G Shoemaker; R Hromas; K Kaushansky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

2.  Selective and indirect modulation of human multipotential and erythroid hematopoietic progenitor cell proliferation by recombinant human activin and inhibin.

Authors:  H E Broxmeyer; L Lu; S Cooper; R H Schwall; A J Mason; K Nikolics
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

Review 3.  Why clinicians should be interested in interleukin-3.

Authors:  P Valent; K Geissler; C Sillaber; K Lechner; P Bettelheim
Journal:  Blut       Date:  1990-12

4.  A human interleukin 3 analog with increased biological and binding activities.

Authors:  A F Lopez; M F Shannon; S Barry; J A Phillips; B Cambareri; M Dottore; P Simmons; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

5.  Hemopoietic colony growth-promoting activities in the plasma of bone marrow transplant recipients.

Authors:  K Yamasaki; L A Solberg; N Jamal; G Lockwood; D Tritchler; J E Curtis; M M Minden; K G Mann; H A Messner
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

6.  Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy.

Authors:  K Kaushansky; V C Broudy; A Grossmann; J Humes; N Lin; H P Ren; M C Bailey; T Papayannopoulou; J W Forstrom; K H Sprugel
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

7.  Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development.

Authors:  K Kaushansky; V C Broudy; N Lin; M J Jorgensen; J McCarty; N Fox; D Zucker-Franklin; C Lofton-Day
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

8.  Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor.

Authors:  M Aglietta; W Piacibello; F Sanavio; A Stacchini; F Aprá; M Schena; C Mossetti; F Carnino; F Caligaris-Cappio; F Gavosto
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

Review 9.  Numerous growth factors can influence in vitro megakaryocytopoiesis.

Authors:  R Hoffman; R Briddell; E Bruno
Journal:  Yale J Biol Med       Date:  1990 Sep-Oct

10.  Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours.

Authors:  M W Dercksen; K Hoekman; W W ten Bokkel Huinink; E M Rankin; R Dubbelman; H van Tinteren; J Wagstaff; H M Pinedo
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.